Optherion Company
%20.jpg)
Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration, dense deposit disease, atypical hemolytic uremic syndrome, and other chronic diseases involving the alternative complement cascade. The company was founded in 2005 and is based in New Haven, Connecticut.
%20.jpg)
Founded Date:
1-1
Headquarters:
New Haven, Connecticut, United States
Technology:
Geroscience
Employee Number:
11-50
Industry:
Biotechnology, Health Care, Medical
Estimated Revenue:
Less than $1M
Funding Status:
Early Stage Venture